Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

BACKGROUND: Stage shift is widely considered a major determinant of the survival benefit conferred by breast cancer screening. However, factors and mechanisms underlying such a prognostic advantage need further clarification. We sought to compare the molecular characteristics of screen detected vs....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Crispo, Anna, Barba, Maddalena, D’Aiuto, Giuseppe, De Laurentiis, Michelino, Grimaldi, Maria, Rinaldo, Massimo, Caolo, Giuseppina, D’Aiuto, Massimiliano, Capasso, Immacolata, Esposito, Emanuela, Amore, Alfonso, Di Bonito, Maurizio, Botti, Gerardo, Montella, Maurizio
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3598199/
https://ncbi.nlm.nih.gov/pubmed/23305429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars